Guidelines

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all (107)

hendrik w. van veen

University of Cambridge

Cambridge, United Kingdom

Specialty Chief Editor

Pharmacology of Infectious Diseases
sevtap arikan-akdagli

Hacettepe University

Ankara, Türkiye

Associate Editor

Pharmacology of Infectious Diseases
horacio bach

University of British Columbia

Vancouver, Canada

Associate Editor

Pharmacology of Infectious Diseases
eliane billaud

Pharmacology APHP Centre Université de Paris

Paris, France

Associate Editor

Pharmacology of Infectious Diseases

Navigation group

Pharmacology of Infectious Diseases

Guidelines

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

hendrik w. van veen

sevtap arikan-akdagli

horacio bach

eliane billaud

Articles

Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study

Exogenous glutathione reverses meropenem resistance in carbapenemresistant Klebsiella pneumoniae

Implementation and Impact of the ing the Global Access (GA) Principles at the University of British Columbia (UBC): Current Successes and Future Challenges , Challenges and Next Steps

Safety and efficacy of lentinan nasal drops in patients infected with the variant of COVID-19: a randomized, placebo-controlled trial

Research Topics

Synergistic and Antagonistic Interactions Between Biogenic Nanoparticles, Bioactive Extracts, and Antibiotics: Their Application as Antimicrobial Agents

Peptides Against Infectious Diseases: From Antimicrobial Peptides to Vaccines

Combinational therapy and nanotechnologies in combating pathogenic microbes and antibiotic resistance

Raising the bar: Advancing therapeutic strategies for fighting communicable and noncommunicable diseases